Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Operating activities      
Net income $ 218,728 $ 193,999 $ 150,548
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 186,898 173,138 160,071
Amortization of intangible and other assets and favorable/unfavorable leases 2,308 2,518 3,899
Amortization of long-term prepaid rents 2,361 1,542 2,625
Amortization of debt issue costs 5,151 5,245 5,476
Amortization of deferred revenues, deferred lease incentives and other (17,163) (13,665) (11,712)
Amortization of bond discount     482
Impairment of long-lived assets 8,801 6,647 3,794
Share based awards compensation expense 15,758 12,818 16,886
(Gain) loss on sale of assets and other 8,143 15,715 (3,845)
Write-off of unamortized debt issue costs, debt discount and accumulated other comprehensive loss related to early retirement of debt     15,688
Deferred lease expenses (1,806) 2,536 5,701
Equity in income of affiliates (28,126) (22,743) (22,682)
Deferred income tax expenses 11,095 526 (37,790)
Interest paid on redemption of senior notes     (8,054)
Distributions from equity investees 19,027 19,172 13,658
Changes in other assets and liabilities:      
Inventories (2,535) 400 (1,539)
Accounts receivable (26,370) 33,804 (15,938)
Income tax receivable (3,527) (18,681) 4,060
Prepaid expenses and other (2,557) 4,011 (3,557)
Deferred charges and other assets - net 8,126 19,713 (17,624)
Accounts payable and accrued expenses 43,827 32,570 48,963
Income tax payable 936 (15,685) 15,035
Liabilities for uncertain tax positions 1,315 (4,437) (14,345)
Other long-term liabilities 5,481 5,491 (134)
Net cash provided by operating activities 455,871 454,634 309,666
Investing activities      
Additions to theatre properties and equipment (331,726) (244,705) (259,670)
Proceeds from sale of theatre properties and equipment and other 9,966 2,545 34,271
Acquisition of theatres in the U.S., net of cash acquired   (7,951) (259,247)
Acquisition of theatre in Brazil (2,651)    
Proceeds from disposition of Mexico theatres     126,167
Investment in joint ventures and other (3,711) (3,228) (6,222)
Net cash used for investing activities (328,122) (253,339) (364,701)
Financing activities      
Proceeds from stock option exercises   112 57
Payroll taxes paid as a result of restricted stock withholdings (4,770) (9,861) (3,464)
Dividends paid to stockholders (115,863) (115,625) (106,045)
Proceeds from issuance of notes     530,000
Other short term borrowings     1,473
Redemption of senior notes     (461,946)
Repayments of other long-term debt (8,420) (9,846) (9,339)
Payment of debt issue costs (6,957)   (9,328)
Payments on capital leases (16,513) (14,035) (12,015)
Purchases of non-controlling interests     (5,621)
Other 1,376 2,422 44
Net cash used for financing activities (151,147) (146,833) (76,184)
Effect of exchange rates on cash and cash equivalents (26,932) (15,522) (11,516)
Increase (decrease) in cash and cash equivalents (50,330) 38,940 (142,735)
Cash and cash equivalents:      
Beginning of period 638,869 599,929 742,664
End of period $ 588,539 $ 638,869 $ 599,929